jamiebell
Vesalio announces presentation of positive CLEAR study results at ESMINT 2023
Vesalio has announced the recent presentation of key findings from the CLEAR study—a prospective, multicentre, open-label, single-arm, US Food and Drug Administration (FDA)-regulated investigational...
Insights from interventional neuroradiologists on coping with severe complications
Given the potentially devastating consequences that can occur if an ischaemic stroke or acute intracranial aneurysm procedure goes wrong, an interventional neuroradiologist’s practice is...
Nevro announces new data demonstrating health economic benefits of 10kHz SCS...
Nevro Corporation has announced the publication of new data validating the health economic benefits of 10kHz therapy, the company’s proprietary, high-frequency spinal cord stimulation...
Microvention enters transradial access market with US FDA clearance of Sofia...
Microvention, a wholly owned subsidiary of Terumo Corporation, announced today that the Sofia EX 5Fr 115cm intracranial support catheter received US Food and Drug...
AI algorithm shows promise for early intracerebral haemorrhage detection in retrospective...
Sheba Medical Center in Tel Aviv, Israel has revealed the results from a “groundbreaking” study in the International Journal of Emergency Medicine, validating an...
ASA seeks to ‘empower’ Hispanic-Latino communities with promotion of RÁPIDO acronym
To help “close the gap between knowledge and action”, the American Stroke Association (ASA) is launching a culturally relevant Spanish-language campaign named ‘Juntos Contra...
Motif conducts first-in-human research of pea-sized brain stimulator for treatment-resistant depression
Motif Neurotech, a company developing minimally invasive bioelectronics for mental health conditions, has announced new research published to the preprint server Medrxiv that demonstrates the use...
Route 92 Medical announces appointment of Jonathan Kennedy as chief financial...
Route 92 Medical has announced the appointment of Jonathan Kennedy to the role of chief financial officer. In this role, Kennedy will be responsible...
Boston Scientific to expand neuromodulation portfolio with Relievant Medsystems acquisition
Boston Scientific Corporation has today announced it has entered into a definitive agreement to acquire Relievant Medsystems—a privately held medical technology company that has...
Cerevasc announces presentation of initial eShunt data at ESMINT 2023
Cerevasc has today announced that findings from a clinical study examining the use of its eShunt system to treat communicating hydrocephalus were recently presented...
Theranica announces new study indicating meaningful impact of Nerivio from as...
Theranica has announced the results of a study, recently published in the journal Pain Management, suggesting the rapid impact of Nerivio—the first and only...
New Pathway to Neurosurgery programme intends to “open doors” for underrepresented...
The Congress of Neurological Surgeons (CNS) Foundation has launched its Pathway to Neurosurgery programme, an initiative dedicated to alleviating healthcare disparities by encouraging high...
Brain Aneurysm Foundation launches ‘Stop the Pop’ campaign
The Brain Aneurysm Foundation (BAF) has announced the launch of ‘Stop the Pop’—a new campaign intended to increase awareness of the prevalence and impact...
NeuroNews’ top 10 most popular stories of August 2023
Several presentations and news stories from this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) ended up among...
Synchron completes enrolment in US COMMAND trial of endovascular brain-computer interface
Synchron has announced completion of patient enrolment in the USA-based COMMAND trial assessing the company’s endovascular brain-computer interface (BCI) technology.
“Giving patients the option to...
‘Minimal differences’ in clinical outcomes between stroke thrombectomy with or without...
There are likely to be minimal differences in clinical outcomes between acute stroke patients presenting directly to endovascular treatment centres who undergo mechanical thrombectomy...
Intrathecal drug delivery effective for managing cancer-related pain, as per existing...
Two separate systematic reviews and meta-analyses—both published recently in Neuromodulation: Technology at the Neural Interface—have concluded that intrathecal drug delivery (IDD) systems are effective...
Observation, creativity and happy accidents: Transitioning from clinical life to industry...
When it comes to advising young physicians on how to navigate the more commercial, industry-entwined commitments that their career will most likely bring further...
The physics of aspiration thrombectomy—what matters?
This advertorial, intended for readers outside the USA only, is sponsored by Penumbra.
Much of the clinical success that can be achieved with aspiration-based mechanical...
Old but still gold—why coiling remains a vital tool for treating...
This advertorial, intended for readers outside the USA only, is sponsored by Medtronic.
Alberto Nania (National Health Service Lothian, Edinburgh, UK) speaks to NeuroNews...
EVT with poor reperfusion linked to worse outcomes than medical management...
Endovascular therapy (EVT) treatments that achieve poor reperfusion have been found to result in inferior clinical outcomes compared to best medical management (BMM) in...
Rapid gains Chinese NMPA regulatory approval for Tigertriever thrombectomy device
Rapid Medical has announced Chinese National Medical Product Administration (NMPA) approval for its adjustable Tigertriever revascularisation device, making it the first device to offer...
Ameer Hassan
Having initially sought out a career in plastic surgery, Ameer Hassan (Harlingen, USA) switched gears to interventional neurology in 2005—a change of heart he...
Mainstay Medical announces completion of US enrolment in RESTORE clinical trial
Mainstay Medical has announced the completion of enrolment in its RESTORE randomised clinical study of ReActiv8 for the treatment of intractable chronic low back...
Novel ‘infraslow pink noise’ stimulation found to be safe and feasible...
A novel brain stimulation technique called high-definition transcranial infraslow pink noise stimulation (HD-tIPNS) was recently evaluated in a placebo-controlled pilot study, and found to...
Brain Navi to showcase NaoTrac and KrystoLens neurosurgical devices at upcoming...
Brain Navi has announced the demonstration of NaoTrac, a neurosurgical navigation robot, and KrystoLens, a single-use neuro-endoscope, at two upcoming conferences: the Congress of Neurological...
Two-year data indicate long-term effectiveness of Nevro’s SCS therapy in painful...
Nevro Corporation recently announced the publication of 24-month data from the SENZA painful diabetic neuropathy (PDN) randomised controlled trial (RCT)—the largest RCT to evaluate...
Mahesh Jayaraman becomes 28th president of the Society of NeuroInterventional Surgery
Mahesh Jayaraman, an interventional neuroradiologist at Rhode Island Hospital in Providence, USA—who has led national efforts to improve stroke systems of care in the...
Medtronic receives CE-mark approval for Inceptiv closed-loop SCS to treat chronic...
Medtronic has received CE-mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator in the treatment of chronic pain.
Inceptiv is the first Medtronic spinal...
Case series indicates effectiveness of direct-current stimulation in multiple sclerosis patients
A case series conducted by Courtney Ellerbusch (Centura Home Health, Colorado, USA) on multiple sclerosis (MS) patients has found quantitative improvements in strength, spasticity,...
Biomarker-guided neuromodulation alleviates memory loss in traumatic brain injury patients
A collaborative study published in the journal Brain Stimulation has shown that targeted electrical stimulation in epilepsy patients with traumatic brain injury (TBI) can...
Continued improvement of flow diverters and intrasacculars holds key to truly...
Laurent Pierot’s (Reims University Hospitals, Reims, France) long career in the treatment of intracranial aneurysms predates not only what many consider to be the...
Missing outcome data is common and ‘does not occur at random’...
The phenomenon of missing outcome data (MOD) within stroke registries of mechanical thrombectomy cases “is not a rare event and does not occur completely...
Massachusetts’ stroke triage updates will save lives and reduce disability, says...
Massachusetts patients experiencing stroke could soon have access to refined treatment, triage and transport protocols based on a provision in the US state’s new...
Nurami receives US FDA 510(k) clearance for resorbable dural repair graft
Nurami Medical, a medical device startup company, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its electrospun nanofibre-based product, ArtiFascia...
Hubly cranial access drill compares favourably to established device in safety...
Hubly Surgical has announced the results from the first peer-reviewed study comparing the safety and efficacy of its recently US Food and Drug Administration...
Enspire announces publication of trial evaluating DBS plus rehab for stroke...
Enspire DBS Therapy has announced the publication of the results of the EDEN trial—an early feasibility study led by Cleveland Clinic (Cleveland, USA) researchers assessing...
Kandu announces positive functional outcomes and low readmission rates in novel...
Kandu Health has announced preliminary outcomes from the first 40 stroke survivors served by its novel stroke recovery programme, which intends to support stroke...
US registry study reveals 75% of acute stroke patients wait more...
A new study led by researchers from the University of Chicago Medicine (Chicago, USA) has revealed that nearly 75% of acute stroke patients wait more than...
Hyperfine completes enrolment for pilot study assessing portable MRI in paediatric...
Hyperfine has announced completed enrolment for HOPE PMR—a multicentre, observational pilot study assessing portable magnetic resonance imaging (MRI) in children with neurological injury, using...
Flow announces pivotal trial results indicating tDCS headset is twice as...
Flow Neuroscience, the creator of the Flow transcranial direct current stimulation (tDCS) headset for at-home, non-invasive brain stimulation to treat depression, has announced the...
Imperative unveils new company structure intended to elevate stroke and vascular...
Imperative Care has announced a new organisational structure designed to accelerate the company’s growth across its businesses. As per an Imperative press release, this...
NeuroNews’ top 10 most popular stories of July 2023
NeuroNews’ 10 most popular stories from July reveal a huge amount of interest in the treatment of stroke patients with medium vessel occlusions (MeVOs)—with...
Health economic data show cost-dominance of Saluda’s EVOKE system over open-loop...
Saluda Medical has announced the publication of new health economic data in the Clinical Journal of Pain that provides “the strongest ever economic case” for the...
Report finds improved thrombectomy access at NHS hospitals using Brainomix’s AI...
More stroke patients are benefitting from life-changing treatment thanks to Brainomix's e-Stroke artificial intelligence (AI) platform, according to a recent report from the Oxford...
Systematic review and meta-analysis find stroke thrombectomy safe and effective in...
A study presented at last week’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August 2023, San Diego, USA) noted that mechanical thrombectomy—in...
‘Care hotel’ model can lower costs and shorten hospital stays after...
Using a ‘care hotel’ model, which discharges patients to a specialty hospital hotel after smaller surgeries, can lower costs and shorten patients’ time in...
Enspire announces US$17.6 million Series B financing to advance DBS plus...
Enspire DBS Therapy recently announced that it has raised US$17.6 million of committed capital in a Series B financing led by existing investor Cleveland Clinic Innovations....
Anuncia announces first successful implant of ReFlow mini flusher in hydrocephalus...
Anuncia Medical has announced the successful first implant of the company's US Food and Drug Administration (FDA)-cleared ReFlow mini flusher device.
Performed on by neurosurgeon Samuel...
Imperative announces late-breaking data showing benefits of ‘angled-tip’ aspiration catheters
Imperative Care has announced late-breaking data from the Neurovascular Quality Initiative-Quality Outcome Database (NVQI-QOD) evaluating its Zoom stroke solution, which were presented at the...
Kernel unveils new Flow2 advancing neuroimaging system
Kernel has unveiled its Flow2 system, which the company claims will give researchers and clinicians “unprecedented access” to robust, functional magnetic resonance imaging (fMRI)-like...
Smartphone app reliably and autonomously recognises physical stroke signs in study
During a late-breaking abstract session at this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA), researchers discussed a...
New study finds surgical approaches safe and effective in ARUBA-eligible unruptured...
Contrary to the results of a seminal study in the field, a recent analysis presented at the Society of NeuroInterventional Surgery (SNIS) annual meeting...
Viz.ai announces study findings demonstrating real-world impact of AI-driven stroke technology
Viz.ai has announced the presentation of three new abstracts that demonstrate the real-world impact of the Viz neuro suite at this week’s Society of...
Less invasive ‘liquid biopsy’ holds potential to identify genetic mutations in...
A study presented yesterday at the Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) indicates that it may be...
EOSolutions announces 510(k) submission of Thinline 8Fr vascular access sheath
EOSolutions has announced the US Food and Drug Administration (FDA) 510(k) submission, through a design consulting firm, of the Thinline 8Fr sheath—a vascular access solution...
New data indicate clinical benefits of Imperative’s Zoom stroke solution in...
Imperative Care has announced multiple new pieces of data from studies evaluating its Zoom stroke solution, presented at the ongoing Society of NeuroInterventional Surgery...
Aidoc launches AI-powered Full Brain solution to “significantly expand” stroke detection
Aidoc has announced the launch of its “revolutionary” Full Brain solution, which the company claims will significantly expand the anatomy analysed by artificial intelligence...
Study indicates filter-tip stent retrievers may improve first-pass thrombectomy rates
Research presented at the ongoing Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) has shown that different types of...
Microvention announces five-year WEB-IT data alongside two new device sizes
Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the publication of five-year follow-up data from the WEB-IT trial and the addition of two...
New eligibility criteria including large-core strokes could boost thrombectomy rates “dramatically”
A study presented on the first day of the 2023 Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) has...
Neurovascular OBLs: Enhancing patient satisfaction and accessibility with advanced biplane systems
This advertorial, sponsored by Siemens Healthineers, is intended for US readers only.
A neurosurgical clinic in Raleigh, USA recently opened an office-based lab (OBL)—specifically, the...
Early administration of antiplatelets may improve post-thrombectomy outcomes in stroke patients
Administering antiplatelet medication within 24 hours of a mechanical thrombectomy procedure may help stroke patients recover more successfully and prevent high-risk individuals from experiencing...
Route 92 announces publication of first-in-human study featuring FreeClimb 70 reperfusion...
Route 92 Medical has today announced the publication of a retrospective, first-in-human study featuring its FreeClimb 70 reperfusion system in the journal Interventional Neuroradiology....
Non-invasive VNS approach could enhance post-stroke recovery outcomes
A novel approach to vagus nerve stimulation (VNS) may enable successful post-stroke recovery without the need for “invasive and often-uninsured” traditional VNS therapies.
A paper published...
Mainstay announces publication of three-year data from post-market follow up of...
Mainstay Medical recently announced the publication of three-year clinical data from the post-market clinical follow-up (PMCF) study of 33 ReActiv8 patients at five medical...
Anuncia announces US launch of second-generation ReFlow device to treat hydrocephalus
Anuncia Medical has announced the successful US commercial launch of the ReFlow mini flusher—a second-generation device for the treatment of hydrocephalus. According to a...
Elevating stroke care: Navigating the transition from primary to comprehensive centres
In a guest piece for NeuroNews, Thomas Devlin (Chattanooga, USA) and Michelle Luffey advise the community on how best to navigate the transition from...
Nicolab and Titan partner to improve prehospital workflows in acute stroke
Nicolab and Titan Neuroscience Research Australia have announced the formal signing of a Memorandum of Understanding (MOU) between the two organisations. The MOU outlines...
Hubly Surgical closes oversubscribed US$3 million seed funding round
Hubly Surgical has successfully closed its Series seed funding round at an oversubscribed US$3 million. As per a company announcement, this investment comes on the...
Nalu presents new study data on pain management with PNS and...
Nalu Medical, a company that has miniaturised neurostimulation implants for the management of chronic intractable pain for both peripheral nerve stimulation (PNS) and spinal...
Imperative gains US FDA clearance for Zoom 88 support and announces...
Imperative Care has announced US Food and Drug Administration (FDA) 510(k) clearance of its Zoom 88 large distal platform (LDP) support, a portfolio expansion...
Arsenal Medical announces treatment of first patient with NeoCast embolic biomaterial
Arsenal Medical has today announced enrolment of the first patient treated with the company’s investigational NeoCast embolic biomaterial for neurovascular conditions.
The patient was successfully...
Recruitment in iVascular’s SEMTIC study passes halfway point
iVascular has announced that the SEMTIC study, evaluating the safety and efficacy of its comprehensive stroke thrombectomy treatment, is one step closer to providing...
“No significant difference” between aspiration and stent-retriever thrombectomy in medium vessel...
When utilised as a first-line technique for medium vessel occlusion (MeVO) stroke, aspiration and stent-retriever thrombectomy have demonstrated “no significant difference” in imaging-related or...
Insightec gains US FDA nod for five-year endpoint in MR-guided focused...
Insightec has announced US Food and Drug Administration (FDA) approval of the five-year study endpoint for what it claims is the largest prospective, long-term...
Magnus announces first treatments in OLO clinical trial of novel depression...
Magnus Medical has announced that the first participants have been treated in the Open Label Optimisation (OLO) clinical trial evaluating the effectiveness of the...
‘Intelligent suit’ supported by AI and electrical stimulation could enhance spinal...
Experts in Germany are working on an ‘intelligent suit’ with which they hope to significantly improve rehabilitation after a serious spinal cord injury. This...
Researchers develop geometric deep learning model with potential to more accurately...
Researchers in Germany have developed a new deep learning model for detecting stroke lesions, claiming that—by leveraging rich geometric information to segment brain stroke...
Interim analysis of MOOD trial produces positive neuromodulation data in depression...
Neurolief has announced positive results from a planned interim analysis of the ongoing, randomised controlled MOOD pivotal trial, which is studying Relivion DP—a novel...
Rapid Medical announces new data showing “significant advantages” of Comaneci for...
Rapid Medical has announced new clinical data demonstrating the “significant advantages” of its novel Comaneci embolisation assist device over established techniques to treat ruptured...
Flow-diverter performance “comparable” between PComAs and other supraclinoid aneurysms
The concluding findings of a systematic review and meta-analysis published in the journal Neurosurgery indicate that flow-diverter performance in posterior communicating artery (PComA) aneurysms...
Cognito presents MRI data showing efficacy of non-invasive gamma stimulation therapy...
Cognito Therapeutics has announced “robust, lobe-specific” changes in white matter volume and myelination in Alzheimer’s disease patients following six months of non-invasive gamma stimulation...
Education and collaboration key to continued advancement of painful diabetic neuropathy...
The neuromodulation space has proliferated significantly over the past few years, and one area in which this is most notable is with the expansion...
First US and French patients enrolled in Philips’ WE-TRUST study
Royal Philips has today announced enrolment of the first patients in both the USA and France into the large-scale WE-TRUST study—a multicentre, prospective randomised...
Research indicates women are less likely to be routed to comprehensive...
Despite having worse stroke symptoms and living within comparable distances to comprehensive stroke centres (CSCs), women with large vessel occlusion (LVO) acute ischaemic stroke...
Craniotomy and decompressive craniectomy achieve similar outcomes in acute subdural haematoma
The two prevailing techniques used during surgical treatments of traumatic acute subdural haematomas (SDHs)—craniotomy and decompressive craniectomy—have demonstrated broadly similar efficacy outcomes in a...
Evren Technologies launches Phoenix 100 system for vagus nerve stimulation research
Evren Technologies has announced the launch of its Phoenix 100 system, a “state-of-the-art” transcutaneous auricular vagus nerve stimulator (taVNS) research tool.
The Phoenix 100 system is intended...
US centre achieves 87% drop in neurosurgical infection rates across two-year...
A US centre has achieved a steep drop in infection rates among its neurosurgery patients over a two-year period thanks to the implementation of...
Stryker announces commercial launch of Q guidance system with cranial guidance...
Stryker has commercially launched its Q guidance system with cranial guidance software to provide surgeons with an image-based planning and intraoperative guidance system that assists...
Flexible nanoelectrodes can “pave the way” for higher-resolution stimulation devices
Engineers at Rice University (Houston, USA) have created nanoelectrodes that are minimally invasive and exceptionally flexible—and, as such, have the potential to function as...
Hyperfine launches international study to assess Swoop system in stroke diagnosis...
Hyperfine, the company that created the Swoop system—which it claims is the world’s first US Food and Drug Administration (FDA)-cleared portable magnetic resonance (MR) brain imaging...
Is thrombectomy set to become the standard of care for medium...
With multiple large clinical trials currently underway to assess thrombectomy treatments in patients with medium vessel occlusion (MeVO) stroke, Johanna Ospel (Calgary, Canada) takes...
ZAP-X gyroscopic radiosurgery platform gains Chinese NMPA approval
ZAP Surgical Systems has announced that the company has received National Medical Products Administration (NMPA) approval in China for its ZAP-X gyroscopic radiosurgery platform.
ZAP-X...
Zeta Surgical announces successful first treatment in neurosurgical navigation study
Zeta Surgical has successfully treated its first patient using the Zeta cranial navigation system as part of a first-in-human trial at the National Neuroscience Institute (NNI)...
Append Medical raises US$4.35 million in initial closing of extended series...
Append Medical has raised US$4.35 million as part of an extended series A round, which will be used to support the company's first-in-human trials of Appligator.
Investors include...
“Definitive trial” needed to confirm desmopressin’s potential in ICH patients receiving...
The results of a clinical trial have shown that a drug commonly used for patients with bleeding disorders has the potential to lessen the...
Highly targeted brain stimulation achieves “very exciting” outcomes in acute ischaemic...
Highly targeted electrical stimulation to the brain has shown promise as a treatment option for acute ischaemic stroke, according to a pilot study led by University...
NeuroNews’ top 10 most popular stories of June 2023
In addition to a number of key study presentations from the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), NeuroNews’ most popular stories...
MindRhythm announces first patient enrolment in pivotal study of novel stroke-detection...
MindRhythm, in partnership with Wayne State University School of Medicine (Detroit, USA), recently announced that the first patient has been enrolled in the pivotal...
Researchers uncover ‘mutant origin’ of intracranial aneurysms and report promising drug...
Researchers at the RIKEN Center for Brain Science (CBS) in Wako, Japan have discovered a set of related mutations that lead to intracranial aneurysms....
Nerivio neuromodulation therapy found to safely treat migraine in pregnant women
Theranica has announced the results of a study recently published in the journal Headache demonstrating the safety of its Nerivio device—a novel remote electrical...
LINNC 2023 examines neuroprotection, steerable microcatheters and other ‘next frontiers’
Neuroprotective agents and steerable microcatheter technologies were among a number of potential new interventional neuroradiology (INR) frontiers showcased and discussed at this year’s LINNC...
First SynerFuse procedure performed by solo surgeon in two-level spinal fusion...
SynerFuse has announced that—for the first time in the world, it claims—a solo spine surgeon has performed the SynerFuse procedure in a two-level spinal...
New ENRICH-PLUS study set to build on recent positivity in haemorrhagic...
Just two months after announcing what it claims is the “world's first positive surgical trial” in haemorrhagic stroke, NICO Corporation is awarding a US$200,000...
Microvention announces commercial availability of ERIC retrieval device in the USA
Microvention, a wholly owned subsidiary of Terumo, has announced that the ERIC retrieval device is now commercially available in the USA for ischaemic stroke treatment, having...
Black patients nearly 50% less likely to receive revascularisation for PAD
A new study from Keck Medicine at the University of Southern California (USC; Los Angeles, USA) has uncovered “significant racial disparities” in the diagnosis, treatment and outcomes of...
US and Chinese experts introduce new aneurysmal subarachnoid haemorrhage guidelines
Expert groups from the USA and China have separately introduced new guidelines relating to the management of aneurysmal subarachnoid haemorrhage (aSAH). The updated guidelines—spearheaded...
LivaNova announces randomisation of 150th bipolar depression patient in RECOVER clinical...
LivaNova has announced that the 150th bipolar depression patient has been randomised in its RECOVER clinical study—a prospective, multicentre, double-blinded randomised controlled trial investigating...
J Mocco
As president of the Society of NeuroInterventional Surgery (SNIS), endovascular neurosurgeon J Mocco (Icahn School of Medicine at Mount Sinai, New York, USA) has...
AptaTargets announces publication of APRIL trial data in JAMA Neurology
As per a press release from AptaTargets, JAMA Neurology has published positive results from APRIL—a Phase 1b/2a clinical trial evaluating the safety and efficacy...
Cochrane Library urged to retract and revise recent SCS review over...
Pain physicians have urged the Cochrane Library to retract and revise a recent review of spinal cord stimulation (SCS) in the treatment of low...
Sensome and Asahi Intecc partner to further development of Clotild smart...
Sensome and Asahi Intecc have today announced a collaboration to develop the next-generation Clotild smart guidewire, with Asahi Intecc taking on the manufacturing role...
Incomplete imaging of transient ischaemic attack increases subsequent stroke risk
Transient ischaemic attacks (TIAs) encountered with incomplete neurovascular imaging in emergency departments (EDs) have been associated with higher odds of subsequent stroke within 90...
Kandu Health appoints new CEO and enrols first 50 patients in...
Imperative Care recently announced the appointment of Kirsten Carroll as the new CEO of Kandu Health—a digital health startup with the aim of improving quality...
Analysis shows substantial cost saving can be achieved with Philips’ DTAS...
Royal Philips has today announced the results of a health economics analysis published in the Journal of NeuroInterventional Surgery (JNIS) that show an “innovative approach” to the...
Vision recovery among potential benefits of endovascular therapy in PCA occlusion...
A multicentre study presented at the recent European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has found that vision recovery and an increased...
Combined neuroprotection therapy shows promise in experimental stroke model
A new study conducted by scientists at Louisiana State University (LSU) Health New Orleans Neuroscience Center of Excellence (New Orleans, USA) reports that the...
Researchers identify novel protein linked to ischaemic stroke risk in older...
By identifying plasma proteomic determinants of incident cardioembolic and non-cardioembolic ischaemic stroke, researchers in the USA have found a novel protein believed to be...
Imperative announces data demonstrating benefits of Zoom RDL system in neurointerventional...
Imperative Care has announced the publication of early clinical data in the Journal of NeuroInterventional Surgery (JNIS) from a single-centre evaluation of the Zoom RDL radial...
Precision Neuroscience begins first-in-human study of implantable BCI technology
Precision Neuroscience Corporation has announced that the first in-human procedures in a pilot clinical study of its neural implant system have been successfully completed....
Neuralace announces upcoming SEAT trial presentation among other clinical milestones
Neuralace Medical has announced the upcoming clinical study presentation of the SEAT randomised controlled trial (RCT), which is assessing the safety and efficacy of...
New study elucidates exact location of atherosclerotic plaque ruptures in carotid...
While the exact location of atherosclerotic plaque ruptures—a common cause of myocardial infarction (MI) and stroke—has previously been unknown, researchers at Lund University (Lund,...
NeuroNews’ top 10 most popular stories of May 2023
While a handful of our highlights from the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) unsurprisingly feature in NeuroNews’ most-read stories through...
MAGNA meta-analysis further supports clinical benefit of EVT in large-core infarct...
The MAGNA meta-analysis of individual patient data (IPD) has provided “strong, generalisable evidence” on the clinically meaningful benefits of endovascular therapy (EVT) in ischaemic...
Early Feasibility Study programme has potential to advance US neurovascular space
At a time when many of Europe’s medical technology markets are effectively going backwards due to complications created by the EU Medical Device Regulation...
Anuncia announces publication of “promising” hydrocephalus outcomes with ReFlow ventricular system
Anuncia Medical has announced that an article highlighting its US Food and Drug Administration (FDA)-cleared and CE-marked ReFlow ventricular system (Gen 1) with hydrocephalus...
Nalu Medical announces first enrolment in peripheral nerve stimulation RCT
Nalu Medical has announced the first patient enrolment in the COMFORT-2 randomised controlled trial (RCT), which will assess the company’s peripheral nerve stimulation (PNS)...
Combined thrombectomy technique fails to demonstrate superiority over aspiration alone
New data from the VECTOR randomised controlled trial—presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany)—have indicated that a mechanical thrombectomy...
NeuroNews issue 50 – US
Highlights:
Positive results with the Woven EndoBridge (WEB; Microvention/Terumo Corporation) device—presented for the first time at the LINNC Americas Seminar (16–17 March, Miami, USA)—indicate...
NeuroNews issue 50 – EU
Highlights:
Positive results with the Woven EndoBridge (WEB; Microvention/Terumo Corporation) device—presented for the first time at the LINNC Americas Seminar (16–17 March, Miami, USA)—indicate...
TESLA trial misses primary endpoint but exhibits “strong suggestion” favouring endovascular...
The results of the TESLA trial were recently presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), demonstrating a “strong suggestion”...
Penumbra expands computer-aided thrombectomy offering with Lightning Bolt 7 launch
Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Bolt 7, which the company claims is the most...
Latest trial results prompt call to “elevate” intracranial haemorrhage management
Following the presentation of new trials assessing intracranial haemorrhage (ICH) treatment approaches, INTERACT3 and ENRICH, Craig Anderson (The George Institute for Global Health, Sydney,...
First surgical cases underway using Stryker’s Q guidance system with cranial...
Stryker has announced that Early Product Surveillance (EPS) cases utilising its Q guidance system with cranial guidance software are underway. The technology provides surgeons with...
IRIS data shed new light on how treatment delays may impact...
A collaboration analysing several major clinical trials has found that endovascular therapy (EVT) plus intravenous thrombolysis (IVT) is likely to be superior to EVT...
Nicolab awarded three-year contract to supply AI-powered stroke software in Australia
Nicolab has been awarded a prestigious three-year contract to supply stroke workflow software and advanced artificial intelligence (AI) diagnostics for the Victorian Stroke Telemedicine...
EOSolutions announces full commercial launch of Dr Banner balloon guide catheter
EOSolutions Corporation has announced the introduction of the Dr Banner balloon guide catheter (BGC), which boasts “unmatched features” for neurovascular procedures. As per a...
Performance feedback significantly reduces door-to-groin time in endovascular therapy
Supplying healthcare providers with performance feedback can significantly reduce the time between an ischaemic stroke patient arriving at a hospital and them subsequently receiving...
Brain-computer interface plus SCS therapy enables thought-controlled walking after spinal cord...
Onward Medical has announced a recent publication in Nature showing that a wireless brain-computer interface (BCI) can use patients’ thoughts to modulate ARC therapy....
“Sonolysis is back” after safely reducing endarterectomy stroke risk in randomised...
Positive results from a clinical trial involving a novel therapeutic procedure known as sonolysis—deployed during a carotid endarterectomy (CEA)—were presented at the recent European...
NeuroOne announces first clinical case using Evo sEEG electrode in robotic...
NeuroOne Medical Technologies has announced the first clinical case using the Evo stereoelectroencephalography (sEEG) electrode in robotic neurosurgery.
Performed by William Bingaman at Cleveland Clinic in Cleveland,...
Pipeline Flex embolisation device deemed safe and effective in complex intracranial...
A retrospective study from China has concluded that the Pipeline Flex embolisation device (Medtronic) is safe and effective in the treatment of complex intracranial...
Artiria granted US FDA clearance for real-time, deflectable guidewire
Artiria Medical, a Swiss neurovascular company, has announced that its real-time, deflectable guidewire has been granted 510(k) clearance by the US Food and Drug...
Interim data find “no evidence of benefit” for carotid revascularisation additional...
Interim results from the ECST-2 randomised controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with...
New data represent “fantastic news” in IVT despite lack of efficacy...
Results from the TIMELESS trial represent “fantastic news” on the safety of intravenous tenecteplase in selected late-window stroke patients, despite the drug failing to...
Structured ambulatory post-stroke care “requires further evaluation” following mixed trial results
While patients treated via a structured ambulatory post-stroke care programme (SANO) in a recent cluster-randomised study experienced better control of their cardiovascular risk factors...
STRIVE-2 neuroimaging standards provide “unique focus” on small vessel disease research
In an attempt to promote more consistent and higher quality research in the field of small vessel disease (SVD), international experts have published the...
Remote ischaemic conditioning fails to improve functional outcomes in acute stroke...
As per results from the RESIST study, remote ischaemic conditioning (RIC)—while not being associated with any major safety issues—has failed to improve functional outcomes...
Early anticoagulation after ischaemic stroke “reasonable” and “unlikely to cause harm”
An international clinical trial presented today at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has demonstrated that—in people with ischaemic stroke...
AI tool outperforms human emergency call handlers in identifying stroke
A team of researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by...
WEB 17 device maintains efficacy, safety across ruptured and unruptured aneurysms
The Woven EndoBridge (WEB) 17 device (Microvention/Terumo Corporation) has demonstrated positive efficacy and safety outcomes in the prospective, multicentre CLEVER study, indicating its utility...
RECOVER trial will provide “thorough understanding” of VNS response in depression...
A new randomised controlled trial (RCT)—the “largest ever” of its kind in the major depressive disorder (MDD) space—will attempt to provide a “thorough understanding”...
Open and endovascular surgery recommended over ligation in ruptured extracranial carotid...
Both open and endovascular surgical approaches are likely to produce improved outcomes compared to ligation in the treatment of ruptured extracranial carotid artery aneurysms....
ChatGPT outperforms medical students and matches residents on neurosurgical board-style questions
An analysis published in the Journal of Neurosurgery, which assessed ChatGPT’s (OpenAI) performance on a surrogate for neurosurgical board-style questions, has found that the...
Abbott gains US FDA nod to treat non-surgical back pain with...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic...
AHA: Systemic interventions key to tackling “enormous inequities” in stroke care
‘Upstream’ causes of health inequities related to stroke—such as structural racism and conditions of the places where people live, learn, work and play—have not...
RapidAI wins MedTech Breakthrough award for best new imaging solution
RapidAI announced recently that its combined haemorrhagic solution—Rapid ICH (intracranial haemorrhage) and Rapid Hyperdensity—has been selected as the “Best New Imaging Solution” in the...
Magnus shares study results indicating SAINT depression treatment changes abnormal brain...
Magnus Medical has shared promising results from a clinical trial published in the Proceedings of the National Academy of Sciences indicating that treatment with SAINT neuromodulation...
Office-based removal of sacral neuromodulation devices deemed safe and well-tolerated
As per a recently published retrospective chart review, the removal of sacral neuromodulation (SNM) devices in the office setting, under local anaesthesia, is a...
Carthera publishes “promising” results with SonoCloud-9 in glioblastoma patients
Carthera has announced the publication in The Lancet Oncology of results from a Phase 1 clinical trial carried out by scientists at Northwestern University...
MR CLEAN-LATE trial finds endovascular therapy safe and effective in late-presenting...
Endovascular therapy (EVT) has been deemed safe and effective in patients with ischaemic stroke caused by an anterior circulation large-vessel occlusion (LVO) who present...
Abbott announces expanded MRI labelling for Eterna spinal cord stimulation system
Abbott has announced that the US Food and Drug Administration (FDA) has approved expanded magnetic resonance imaging (MRI) labelling for its Eterna spinal cord...
European Academy of Neurology launches collaboration to address global brain disorder...
Earlier this week, the European Academy of Neurology (EAN) announced the launch of the Brain Health Mission, a collaborative initiative that aims to address...
‘We need better tools’—new intracranial stent devices required for rare stroke...
“Overall, we just need better tools” was one of the salient points delivered by Jane Khalife (Cooper University Health Care, Camden, USA) in a...
Hubly Surgical gains US FDA clearance for novel burr-hole placement device
Hubly Surgical has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Hubly Drill, which the company describes as an innovative...
Get Ahead of Stroke campaign launches Survive Stroke Week from 15–21...
The Get Ahead of Stroke campaign is launching Survive Stroke Week from 15–21 May—an observance aimed at increasing awareness of stroke symptoms and the...
World-renowned clot science drives outstanding EMBOTRAP stent retriever outcomes in MASTRO...
This advertorial is sponsored by CERENOVUS.
The EMBOTRAP® family of revascularisation devices (CERENOVUS) is innovative within the stent retriever space due to its differentiated design...
Cerevasc to present data on minimally invasive CNS delivery system at...
Cerevasc has announced that data on its minimally invasive central nervous system (CNS) delivery system will be presented for the first time at the...
Computing the future: Exploring ChatGPT’s potential role in neurosurgical practice
Brian Fiani (Livonia, USA) and Ryan Jarrah (Rochester, USA) take a look at the neurosurgical implications of one of the hottest topics permeating not...
Systematic review queries how far PPTA aneurysm management is along “the...
A systematic review and analysis published in the journal Interventional Neuroradiology has examined how far along “the right path” management paradigms for persistent primitive trigeminal artery...
ConcertAI’s TeraRecon announces release of AI-driven Neuro Suite
ConcertAI's TeraRecon has announced the release of Neuro Suite, its artificial intelligence (AI)-driven clinical suite, which the company claims is purpose-built for disease triage,...
MIVI completes enrolment for study of Q revascularisation system in acute...
MIVI Neuroscience has announced that it has completed enrolment in the EVAQ clinical trial to assess the safety and effectiveness of the Q revascularisation system...
Medical therapy improvements mean “the time has come” to reconduct prior...
“The time has definitely come to look at the evidence, and redo these studies,” posited Alun Davies (Imperial College London, London, UK), putting forward...
Clinical stroke research in Canada receives million-dollar grant boost
The Heart and Stroke Foundation, Brain Canada, and the Canadian Stroke Consortium, have announced the recipients of the 2022 Stroke Clinical Research Catalyst grants. The purpose of this...
NeuroNews’ top 10 most popular stories of April 2023
A number of potentially contentious issues caught the eye of our readers in April—including how best to define 'success' in stroke thrombectomy; efforts to...
NeuroOne announces US commercial launch of Evo sEEG electrodes
NeuroOne Medical Technologies has announced the commercial launch of the Evo stereoelectroencephalography (sEEG) electrode product line in the USA.
Zimmer Biomet holds exclusive worldwide distribution rights...
Feinstein Institutes awarded US$3.4 million to study rTMS therapy in schizophrenia
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) have received a US$3.4 million grant from Wellcome to study repetitive transcranial magnetic stimulation (rTMS) and its effects—potentially opening...
Stryker completes acquisition of Cerus Endovascular
Stryker announced today that it has completed the acquisition of Cerus Endovascular—a medical device company engaged in the design and development of neurointerventional devices...
Study finds worse post-stroke neurologic outcomes in Spanish-speaking Americans
New research has indicated that Mexican Americans have worse outcomes after a stroke than non-Hispanic white Americans.
A recent study, which looked at whether the...
Cerenovus announces commercial availability of Cerepak detachable coils in USA
Cerenovus has announced that the new Cerepak detachable coils are now commercially available in the USA, and that the first patient cases have been...
Early diagnosis and treatment needed in “often underreported” post-stroke cognitive impairment
More than half of all stroke survivors may develop cognitive impairment within a year after their stroke, and one in three are at risk for developing dementia...
ESOC to return with fully on-site format and diverse stroke programme
Having taken place via a virtual format in 2021, and as a hybrid meeting last year, the 2023 European Stroke Organisation Conference (ESOC; 24–26...
SynerFuse announces presentation of IDE proof-of-concept study data
SynerFuse has announced that Michael Park (University of Minnesota, Minneapolis, USA)—principal investigator for the company’s investigational device exemption (IDE) proof-of-concept study—presented data from the study’s...
Vascular community split over “death” of traditional carotid stenting
A debate between two prominent carotid interventionists—Peter Schneider (University of California San Francisco, San Francisco, USA) and Domenico Valenti (King's College London, London, UK)—on...
Penumbra launches new RED 43 reperfusion catheter for mechanical thrombectomy
Penumbra recently announced the launch of the latest addition to its RED family of catheter devices for mechanical thrombectomy, the RED 43 reperfusion catheter.
According...
NICO announces initial positive results from ENRICH trial
NICO Corporation has announced initial positive results from the completed ENRICH trial at the 2023 American Association of Neurological Surgeons (AANS) annual scientific meeting...
Route 92 gains US FDA clearance for complete stroke treatment system
Route 92 Medical has today announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its FreeClimb 70 reperfusion system,...
Biotronik announces US FDA approval of Prospera spinal cord stimulation system
Biotronik has announced US Food and Drug Administration (FDA) approval for Prospera—a new spinal cord stimulation (SCS) system. The system features RESONANCE, which the...
Cercare and ConcertAI partner to improve neurovascular clinical workflows
Cercare Medical has announced it will be bringing its neurovascular clinical workflows into ConcertAI's TeraRecon Eureka clinical artificial intelligence (AI) platform as part of...
ENRICH trial data on minimally invasive ICH surgery to be presented...
NICO Corporation has announced that the results from the completed ENRICH trial will be presented at the annual American Association of Neurological Surgeons (AANS)...
RapidAI receives US FDA 510(k) clearance for new imaging product to...
RapidAI announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for Rapid non-contrast computed tomography (NCCT) Stroke, which is...
New WIST guidelines seek to improve access and standardise training in...
A new set of guidelines intended to standardise and expand stroke thrombectomy training have been published simultaneously in Europe, in the journal Advances in...
Nerivio demonstrates real-world effectiveness as migraine treatment in adolescents
Theranica recently had the results from a real-world analysis of Nerivio for acute treatment of migraine in adolescents published in the journal Pediatric Neurology....
Michael J Fox Foundation announces “significant breakthrough” in search for Parkinson’s...
A “landmark” paper published in The Lancet Neurology by leaders of the Parkinson's Progression Markers Initiative (PPMI)—a study sponsored by The Michael J Fox Foundation (MJFF)...
The new standard for SCS therapy—neural activation measurement, targeting and maintenance
Jason Pope (Santa Rosa, USA) discusses closed-loop spinal cord stimulation (SCS) and its potential to provide sustained, holistic outcomes for chronic pain patients. In...
Initial cases indicate lithotripsy can help TCAR expand into high-risk patients
Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery...
Adept launches Adducted Arm Scoop product for use during image-guided procedures
Adept Medical has launched the Adducted Arm Scoop—an improved solution for supporting the adducted arms of supine patients during image-guided procedures.
Adept’s new, “extremely durable”...
Saluda, Neuromod, Neuvotion secure funding rounds to boost neuromodulation technologies
This week, three companies developing novel neuromodulation technologies for use in the treatment of various neurological disorders have each separately announced the receipt of...
Evidence indicates effectiveness of brain stimulation in upper-limb stroke rehabilitation
Moderate- to high-quality evidence suggests that specific neuromodulation modalities can provide effective treatments in patients undergoing stroke rehabilitation. As per a systematic review and...
Annalise.ai gains seven new 510(k) clearances for brain and chest imaging...
Annalise.ai has received US Food and Drug Administration (FDA) 510(k) clearances covering an additional seven findings as part of the company's innovative artificial intelligence...
DAPT at discharge reduces stroke and mortality risk versus other drug...
A recent data presentation has revealed reduced risk of stroke and mortality among transcarotid artery revascularisation (TCAR) patients who receive dual antiplatelet therapy (DAPT),...
Reach Neuro receives Breakthrough Device designation for restorative stimulation device in...
Reach Neuro has been granted a Breakthrough Device designation by the US Food and Drug Administration (FDA) for its Avantis platform, which uses small...
Tenecteplase linked to higher haemorrhage rates than alteplase in no-thrombectomy stroke...
Intravenous tenecteplase was associated with a higher rate of intracranial haemorrhage (ICH), as compared to alteplase, in a recent analysis of real-world data from...
New study shows benefits of BioWave’s peripheral nerve stimulation in chronic...
The peer-reviewed journal Pain and Therapy recently published a new study, titled "Reduced pain and improved function following short-term use of non-invasive BioWave high-frequency peripheral...
First-pass effect or rule of three? Definition of procedural success remains...
While a number of companies in the neurovascular space have become increasingly focused on the ‘first-pass effect’ in mechanical thrombectomy treatments, many major clinical...
Intraoperative adverse events found to impede favourable outcomes in microsurgical aneurysm...
A nationwide study drawing on data from Swedish patients has indicated that—while the majority of ruptured intracranial aneurysm patients treated with microsurgery experienced favourable...
New spectroscopy probe could enhance deep brain stimulation procedures for Parkinson’s
A new probe that performs two types of spectroscopy could make deep brain stimulation (DBS) procedures safer and improve success rates by helping doctors...
Paediatric case helps highlight benefit of ‘aspiration first’ in young stroke...
A unique case presentation at this year’s LINNC Americas Seminar (16–17 March, Miami, USA) saw Rafael de Oliveira Sillero (University of Texas Southwestern Medical...
Astrocyte to initiate extended infusion Phase 1b study of cerebroprotective drug
Astrocyte Pharmaceuticals has announced the initiation of a Phase 1b study of its lead cerebroprotective candidate, AST-004, as an extended infusion in healthy volunteers....
CHI Memorial announces participation in “milestone” stroke study with novel ultrasound...
The Catholic Health Initiatives (CHI) Memorial Stroke and Neuroscience Center has announced its participation in the national research study, BUBL, stating that it was...
Stent-assisted coiling fails to show superiority versus coiling alone in unruptured...
A randomised controlled trial (RCT) involving more than 200 patients has indicated that stent-assisted coiling (SAC) is not superior to coiling alone in unruptured...
NeuroNews’ top 10 most popular stories of March 2023
In addition to the US approval of a unique neurovascular device, discussions around female physicians in the neurointerventional space; pushback against the European Union’s...
Review concludes SCS benefits do not outweigh associated risks and costs...
A recently published Cochrane review has concluded that the clinical benefits of spinal cord stimulation (SCS) do not outweigh the risks and costs associated...
NeuroNews issue 49 – US
Highlights:
The 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) is punctuated by new data on neuroprotective medications in ischaemic stroke, sparking tempered...
NeuroNews issue 49 – EU
Highlights:
The 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) is punctuated by new data on neuroprotective medications in ischaemic stroke, sparking tempered...
Trial underway involving neurointerventionist “retaliated against” for refusing concurrent on-call shifts
The opening statements and presentation of evidence are set for 10am PST today in a lawsuit involving claims that a medical doctor and his...
Chest, Heart and Stroke Scotland applauds decision to reinstate “vital” thrombectomy...
The charity Chest, Heart and Stroke Scotland (CHSS) has voiced support for the Scottish government’s decision to reinstate “vital” funding of thrombectomy services across...
Dual antiplatelet therapy linked to better post-TCAR outcomes versus other drug...
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid artery...
Q’Apel Medical granted CE-mark approval for Walrus balloon guide catheter
Q'Apel Medical has been granted a CE mark under the European Medical Device Regulation (MDR) for Walrus, its balloon guide catheter (BGC) product used...
Vitor Mendes Pereira
As medical accolades go, performing the world’s first robot-assisted neurointerventional procedure—a feat that Vitor Mendes Pereira and his team achieved back in 2019—is something...
Cerevasc appoints Adel Malek as its new chief medical officer
Cerevasc has named neurosurgeon Adel Malek as its new chief medical officer. This appointment will allow the company to further accelerate the development and clinical...
Brain Aneurysm Foundation welcomes Carolina Maier to its board of directors
The Brain Aneurysm Foundation (BAF), a leading global research and advocacy organisation committed to improving treatment and care for brain aneurysms, has announced the addition...
Lessons learned from establishing a 24/7 stroke thrombectomy service
Alongside his colleagues at the Barts Health NHS Trust, Levansri Makalanda (London, UK) was responsible for setting up the second ever 24/7 mechanical thrombectomy...
Recent addition to European flow diverter market performs well in multicentre...
A recent addition to Europe’s flow diversion market—the Derivo 2 embolisation device (DED2; Acandis)—has demonstrated promise in a small-scale, multicentre study, providing a safe...
Athersys announces changes to MASTERS-2 trial endpoints following US FDA meeting
Athersys has announced planned amendments to its MASTERS-2 clinical trial protocol following a Type B meeting with the US Food and Drug Administration (FDA)....
Brainomix receives US FDA clearance for flagship stroke AI imaging software
Brainomix has today announced that its 360 e-ASPECTS tool for stroke has received US Food and Drug Administration (FDA) clearance, enabling the company to...
COMMAND trial set to begin enrolment at third US site
Synchron has announced that the COMMAND trial assessing its endovascular brain-computer interface (BCI) technology is commencing enrolment at Gates Vascular Institute, a Kaleida Health...
Female physicians in neurointerventional surgery: Breaking down barriers
In the latter stages of 2022, the Society of NeuroInterventional Surgery (SNIS) released a position statement advocating pregnancy and parental leave policies in neurointerventional...
UK MHRA awarded £10 million to fast-track patient access to medical...
A total of £10 million has been awarded to the Medicines and Healthcare products Regulatory Agency (MHRA)—an executive agency of the UK Department of...
ObvioHealth to conduct decentralised trial with Mi-Helper device for treatment of...
ObvioHealth and Mi-Helper have announced a partnership to conduct a decentralised clinical trial with a small, non-invasive neuromodulation device for the treatment of migraines. The...
NeuroOne completes initial animal implant of thin-film paddle lead for spinal...
NeuroOne Medical Technologies has announced the successful completion of an initial animal implant of its novel, thin-film paddle leads for spinal cord stimulation (SCS)....
MindRhythm announces publication of EPISODE-PS trial data on ischaemic stroke detection...
MindRhythm, in partnership with Wayne State University School of Medicine (Detroit, USA), has announced the first publication of results from its EPISODE-PS trial in...
Dystonia patient undergoes successful brain pacemaker surgery while watching cartoons
A dystonia patient in Turkey who had been having uncontrollable involuntary contractions in her legs and arms for the past five years recently underwent...
Scientia receives US FDA clearance for Aristotle Colossus macrowire
Scientia Vascular has announced the US Food and Drug Administration (FDA) 510(k) clearance of the Aristotle Colossus macrowire. The company claims that this device...
Carthera and US FDA align on key aspects of potential pivotal...
Carthera, which develops the Sonocloud—an ultrasound-based medical device used to treat a wide range of brain diseases—has announced today the completion of an end-of-Phase...
European Society for Brain Stimulation “strongly opposes” reclassification of non-invasive devices
The European Society for Brain Stimulation (ESBS) has said it “strongly opposes” the European Union’s (EU) recent decision to reclassify non-invasive brain stimulation (NIBS)...
Get Ahead of Stroke campaign debuts new online resources for EMS...
With Brain Awareness Week (13–19 March) approaching, the Get Ahead of Stroke campaign has announced it is debuting new online resources for emergency medical...
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death...
Study finds “dismally low” global access to thrombectomy and “enormous disparity”...
The Society of Vascular and Interventional Neurology (SVIN) has released its first global analysis of access to mechanical thrombectomy for the treatment of large...
Neuromod gains US FDA approval for bimodal neuromodulation tinnitus treatment
Neuromod Devices has announced that the US Food and Drug Administration (FDA) has granted de novo approval to Lenire—the first bimodal neuromodulation device of its kind...
Nevro announces full US market launch of HFX iQ spinal cord...
Nevro Corporation announced today that it has now initiated the full US market launch of its HFX iQ spinal cord stimulation (SCS) system, following...
Five-year project sets out to improve brain aneurysm treatments with customisable...
A team from the University of Oklahoma (Norman, USA) has embarked on a five-year research project with the intention of designing a device that...
Minneapolis hospital opens “nation’s first” paediatric hybrid intraoperative MRI neurosurgery suite
Children's Minnesota (Minneapolis, USA) has claimed, in a press release, to have become the first health system in North America to open a paediatric hybrid intraoperative magnetic resonance...
Mainstay announces publication detailing economic impact of restorative neurostimulation
Mainstay Medical has announced the publication of a paper, titled “Effect of Restorative Neurostimulation on Major Drivers of Chronic Low Back Pain Economic Impact",...
Spinal cord stimulation found to “instantly improve” post-stroke arm and hand...
Spinal cord stimulation (SCS) therapy has been shown to trigger instant improvements in arm and hand mobility, enabling people affected by moderate-to-severe stroke to...
US physicians publish “first reported use” of Indigo aspiration system for...
Physicians in the USA have published details of—to their knowledge—the “first reported use” of the Indigo aspiration system (Penumbra) to treat cerebral venous sinus...
Increasing coiling porosity demonstrates greater impact in male cerebral aneurysm patients
Altering the porosity of coiling in the treatment of cerebral aneurysms has been found to have a greater impact on maximum oscillatory shear index...
NeuroNews’ top 10 most popular stories of February 2023
Stroke research was the flavour of the month throughout February on NeuroNews, with highlights from the International Stroke Conference (ISC; 8–10 February, Dallas, USA)...
Drug-free migraine treatment gains additional US FDA clearance for preventative use
Theranica has announced that its drug-free Nerivio prescription wearable recently received US Food and Drug Administration (FDA) clearance as a dual-use acute and preventive...
NovaSignal announces donation of NovaGuide 2 intelligent ultrasound system to Jacobs...
NovaSignal has today announced the donation of a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA in order to advance stroke...
Feinstein Institutes reports on early vagus nerve mapping and details novel...
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) are microscopically mapping more than 100,000 individual fibres that make up the vagus nerve...
Route 92 announces 80th patent for Monopoint operating platform
Route 92 Medical has today announced the issuance of the company’s 80th global patent for its Monopoint operating platform. Route 92 claims this is...
High-frequency spinal cord stimulation may be associated with “significant decrease” in...
High-frequency spinal cord stimulation (HF-SCS) for treating chronic refractory low back pain (CRLBP) may be associated with a significant decrease in total healthcare costs,...
Methinks receives CE-mark certification for AI-based stroke triage software
Methinks has announced receipt of a CE mark for its artificial intelligence (AI)-based medical imaging software, Methinks Stroke Suite, following a milestone year of...
Hotter weather during transportation associated with improved thrombectomy outcomes
A study intended to examine the impact of different weather conditions and modes of transport on mechanical thrombectomies in stroke patients has found a...
Uric acid-based neuroprotective agent demonstrates promise in large animal study
The opening day of the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) saw the presentation of findings from an animal-model study that...
Cognito announces first patient enrolment in US pivotal study of novel...
Cognito Therapeutics has announced the first patient enrolment in its US pivotal study, HOPE, which is designed to demonstrate the safety and efficacy of...
Vesalio announces successful initial use of NeVa VS device in USA
Vesalio has announced the successful initial use of its NeVa VS device in the USA for the treatment of post-aneurysmal subarachnoid haemorrhage (aSAH) cerebral...
Incepto partners with Avicenna.AI to improve stroke management in Europe
Incepto, a distributor and co-creator of artificial intelligence (AI) solutions applied to medical imaging, has signed a partnership with Avicenna.AI to enrich its platform...
Randomised trial fails to show benefit with bypass surgery in symptomatic...
The initial findings from a recent randomised controlled trial (RCT) do not support the addition of extracranial to intracranial (EC-IC) bypass surgery to the...
ANGEL-ASPECT data bolster evidence for thrombectomy in large infarct core stroke
A randomised trial has found mechanical thrombectomy procedures performed within 24 hours of symptom onset to be more effective than standard medical care in...
Brainomix technology integrated into new UK atrial fibrillation study
Brainomix has announced its involvement in a new study sponsored by the University of Liverpool (Liverpool, UK) focused on post-stroke atrial fibrillation (AF). Sites...
Trend toward gender parity in faculty “has not translated” to stroke...
The favourable trend toward gender parity that has been seen within neurology faculty over the past decade “has not translated” to the leadership of...
Viz.ai collaborates with Johns Hopkins to expedite patient enrolment in brain...
Viz.ai has announced a collaboration with BIOS Clinical Trials Coordinating Center (BIOS CTTC) at Johns Hopkins University (Baltimore, USA) to expedite patient enrolment for...
Thrombectomy appears comparable to medical management in treating ACA occlusion stroke
Mechanical thrombectomy appears to be a safe and technically feasible treatment option for ischaemic strokes caused by primary isolated anterior cerebral artery (ACA) occlusions...
Dual antiplatelet therapy comparable to thrombolysis in minor, non-disabling ischaemic stroke
Among Chinese patients with minor, non-disabling stroke presenting <4.5 hours from symptom onset, dual antiplatelet therapy (DAPT) has been found to be non-inferior to...
The positive clinical impact of a comprehensive, compatible stroke solutions portfolio
This advertorial is sponsored by CERENOVUS.
Following the recent addition of the EMBOGUARD balloon guide catheter (BGC) to the CERENOVUS STROKE SOLUTIONSi portfolio of devices,...
Randomised trial finds active tDCS to be effective treatment in women...
A randomised, triple-blinded clinical trial involving 35 women has found that active transcranial direct current stimulation (tDCS)—delivered at an intensity of 2mA and across...
Rhaeos raises US$10.5 million in Series A funding to boost hydrocephalus...
Rhaeos has announced the successful closing of US$10.5 million in Series A funding, led by the Steele Foundation for Hope, bringing the company’s total funding to more...
Athersys granted clinical Type B meeting with US FDA to discuss...
Athersys, the company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced recently that it has been granted a clinical Type B meeting with...
New certifications aim to standardise and improve stroke care in Mexico
Hospital institutions in Mexico will have access to a single, comprehensive set of stroke certification services through a new collaboration between the Mexican stroke...
Perfuze announces US FDA clearance and first US clinical use of...
Perfuze has secured its first product clearance from the US Food and Drug Administration (FDA) for the company’s Millipede 088 access catheter. The first...
MindMaze launches Izar neurological rehabilitation device in USA and Europe
MindMaze has announced the US and EU launch of Izar, which it describes as a “first-of-its-kind”, US Food and Drug Administration (FDA)-listed and CE-marked...
Celery seed derivative shows promise as neuroprotectant in acute ischaemic stroke
Ischaemic stroke patients treated with a clot-busting medication and/or mechanical thrombectomy who also received butylphthalide—a novel medication initially compounded from celery seed—experienced milder neurological...
IRRAflow system leads to favourable clinical outcomes versus passive drainage in...
IRRAS has announced the publication of the first comparative study detailing the use of the company's novel IRRAflow system. This study, which was conducted under the...
Chinese TRACE II trial deems tenecteplase non-inferior to alteplase in ischaemic...
New data on intravenous tenecteplase indicate that it can achieve comparable efficacy and safety to alteplase in treating stroke—and, as such, may be used...
New smartphone app may help to identify stroke symptoms as they...
A new smartphone application called FAST.AI (Neuronics Medical) may help people who are having a stroke—or their family and caregivers—to recognise common stroke symptoms in real...
Wallaby/Phenox announces presentation of PROST trial data at ISC 2023
Phenox, a Wallaby Medical company, has today announced the presentation of the primary results of the PROST (Preset for occlusive stroke treatment) randomised clinical...
EndoStream announces first patient enrolment in TORNADO-US study
EndoStream Medical has announced that the first patient has been enrolled in the TORNADO-US clinical study in the USA, which will evaluate the Nautilus intrasaccular system...
SELECT2 results support thrombectomy use in stroke patients with large infarct-core...
An international clinical study has found that patients experiencing a ‘large’ stroke—characterised by a greater infarct-core volume on imaging—had a dramatically better recovery after...
ISC 2023 sees presentation of positive data on new stroke drugs...
New data pointing to the possible advantages held by several drug products in treating acute ischaemic stroke were delivered at the recent International Stroke...
Blood pressure lowering after EVT “should be customised” owing to safety...
The administration of medications to lower systolic blood pressure in acute ischaemic stroke patients who have undergone a successful mechanical thrombectomy procedure—also known as...
Hyperfine announces new data on portable MRI in post-thrombectomy stroke patients
Hyperfine has announced the presentation of new stroke patient follow-up data regarding the use of the Swoop system—which it claims is the world’s first US...
Two cardiovascular medicines found to be “well-tolerated” in small vessel stroke
A study of two widely used cardiovascular medications—cilostazol and isosorbide mononitrate—in more than 350 patients has confirmed that both were well-tolerated and safe for...
Wallaby/Phenox announces US FDA clearance of Preset thrombectomy device
Phenox, a Wallaby Medical company, has announced the US Food and Drug Administration (FDA) 510(k) clearance of its Preset thrombectomy device for the treatment...
Continuous monitoring detects atrial fibrillation in 20% of atherosclerotic stroke survivors
In a study presented yesterday at the International Stroke Conference (ISC; 8–10 February, Dallas, USA), irregular heart rhythms were detected in roughly one in...
Real-world study demonstrates “highly clinically important” time saving with Viz platform
Viz.ai and TeleSpecialists have announced new data presented at the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) from the VALIDATE study, which...
Neuroprotective agent linked to reduced death and disability in ischaemic stroke...
ApTOLL, a neuroprotectant medication intended to shield the brain from tissue damage, has been linked to reduced death and disability when used alongside standard...
Avicenna.AI announces total funding of US$10 million after securing Series A...
Avicenna.AI announced today that it has secured a Series A funding round, bringing aggregated investment in the company close to US$10 million. The round...
Imperative Care announces formation of digital stroke recovery company Kandu Health
Imperative Care has announced the formation of digital health startup Kandu Health as an independent company, with the aim of “changing the course of stroke...
Prior thrombolysis improves outcomes for M2 occlusion stroke patients undergoing thrombectomy
Intravenous thrombolysis (IVT) prior to a mechanical thrombectomy procedure could result in better functional outcomes than thrombectomy alone in stroke patients with M2 occlusions,...
New AHA statement should be seen as “call to action” in...
A new American Heart Association (AHA) scientific statement provides guidance on staffing, leadership and resource requirements for hospital stroke centres, with the intention of...
Czech study finds thrombectomy and IVT rates “remained unchanged” during first...
A national study conducted by researchers in the Czech Republic has found that, while stroke admissions in the country declined during the first year...
Equivalency to clinical practice “varies considerably” across recent carotid intervention trials
The external validity—in other words, the transferability to real-world clinical practice—of contemporary randomised controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably”, as...
New JMIR journal to focus on “intersection between clinical neuroscience and...
JMIR Publications has announced the expansion of its journal portfolio with JMIR Neurotechnology (JNT)—an open-access, peer-reviewed journal focused on the intersection between clinical neuroscience and...
SCS therapies can play a role in cancer-related pain treatment despite...
Spinal cord stimulation (SCS) therapies targeting the dorsal column “may be considered” within the multimodal treatment plans typically required by cancer patients, but it...
LivaNova launches new vagus nerve stimulation therapy for drug-resistant epilepsy
LivaNova has launched SenTiva DUO—an implantable pulse generator (IPG) with a dual-pin header intended to provide vagus nerve stimulation (VNS) therapy for patients with...
Meta-analysis including recent basilar trials signals benefit of EVT in posterior...
A meta-analysis of recent basilar artery occlusion trials—including ATTENTION and BAOCHE—has further indicated the potential benefits held by endovascular therapy (EVT) in treating posterior-circulation...
NeuroNews’ top 10 most popular stories of January 2023
The latest and greatest in neurointerventional technologies feature among NeuroNews’ most read stories from January, including a direct intravascular imaging tool; a new, stroke-specific...
Basking Biosciences to present trial data on novel reversible thrombolytic agent...
Basking Biosciences has announced that it will be presenting three oral presentations and two moderated posters concerning the company’s novel drug candidate—a reversible thrombolytic...
Axonics receives US FDA approval for fourth-generation rechargeable sacral neuromodulation system
Axonics has announced that the US Food and Drug Administration has approved the company’s fourth-generation rechargeable sacral neuromodulation (SNM) system—a technology intended to provide...
Sex found to be “important variable” in study and treatment of...
A systematic review and meta-analysis have demonstrated “convincing evidence” that sex differences exist in carotid atherosclerosis, with all types of plaque features—including those relating...
Global societies lead tributes to esteemed neurologist Ralph Sacco
Esteemed neurologist Ralph Sacco passed away at the age of 65 earlier this month, and a number of prominent neurology and stroke societies have...
Boston Scientific announces three-month data from SOLIS trial at NANS
Combination spinal cord stimulation (SCS) therapy with Boston Scientific’s WaveWriter system has demonstrated superior outcomes to conventional medical management (CMM) in chronic pain patients...
Thrombectomy use rates underscore recent advances in Latin American stroke care
A systematic review of interventional acute ischaemic stroke treatments in Latin American countries has found that mechanical thrombectomy usage in these regions is “comparable...
Infinity Neuro receives CE-mark approval for aspiration catheter to treat stroke
Infinity Neuro announced today that its Inspira aspiration catheters have received CE-mark approval and are now commercially available in Europe.
This is the first offering from...
Abbott gains US FDA approval for SCS therapy in painful diabetic...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful...
Transcutaneous auricular VNS proves effective in patients with mild cognitive impairment
A double-blinded randomised controlled trial (RCT) has shown that transcutaneous auricular vagus nerve stimulation (taVNS) can improve cognitive performance in patients with mild cognitive...
CELLO II balloon guide catheter gains US FDA approval for peripheral...
The CELLO II balloon guide catheter (Fuji Systems Corporation) has received 510(k) premarket approval from the US Food and Drug Administration (FDA), and can...
Blackford and Brainomix announce partnership to advance AI-assisted stroke care
Blackford—an artificial intelligence (AI) imaging platform and solutions provider—is set to form a strategic partnership with Brainomix to bring the latter’s comprehensive e-Stroke solution...
Chinese MATCH study finds microsurgery is “dominant” brain AVM treatment
Researchers have explored the therapeutic outcomes of patients with brain arteriovenous malformations (AVMs) in mainland China and produced early findings indicating that microsurgery is...
Hospitals without high-level designation more likely to miss strokes following TAVI...
A study conducted by Michigan Medicine (Ann Arbor, USA) researchers suggests that hospitals without the highest stroke care designation may be missing strokes that...
ENCHANTED2/MT data indicate intensive blood pressure lowering “should be avoided” after...
Recently published data from the ENCHANTED2/MT study have shed new light on the safety and efficacy of more intensive versus less intensive blood pressure...
Clinical trial to test novel wearable treatment for chronic pain and...
A multi-year clinical trial at the University of Texas Medical Branch (UTMB; Galveston, USA) and Medical University of South Carolina (MUSC; Charleston, USA) will...
Novel digital intervention meets primary endpoint in chronic stroke trial
MedRhythms has announced that the company's pivotal trial for MR-001, a novel digital intervention being developed to treat gait deficits in chronic stroke, was...
Basecamp Vascular announces upcoming appointment of new CEO
Basecamp Vascular (BCV) has announced the appointment of Thierry Col as its new CEO, effective 1 February 2023.
He succeeds interventional neuroradiologist Raphaël Blanc (Foundation Rothschild...
Challenging the status quo in stroke care
This advertorial is sponsored by Philips.
Time is of the essence when treating a patient who has just experienced a stroke. Every minute counts, and...
AHA statement: Even transient stroke symptoms require emergency assessment
Stroke symptoms that disappear in under an hour—often referred to as a transient ischaemic attack (TIA)—need emergency assessment to help prevent a full stroke,...
Squid liquid embolic agent deemed safe and effective for high-grade DAVFs
The Squid liquid embolic agent (Balt) has been deemed safe and effective in treating high-grade dural arteriovenous fistulas (DAVFs), and serves to expand the...
Saluda Medical announces presentation of 36-month EVOKE trial data at NANS...
Saluda Medical has announced that late-breaking data from the "landmark" EVOKE clinical trial was presented at the recent North American Neuromodulation Society (NANS) annual...
Atrial fibrillation does not modify treatment effect of bridging thrombolysis, study...
An international study conducted by Leonard Yeo (National University Hospital, Singapore) and colleagues has found that the presence of atrial fibrillation does not modify...
Abbott presents new data on streamlining patient-reported measures, BurstDR and more...
Abbott presented new data in more than 30 presentations and posters at the North American Neuromodulation Society (NANS) annual meeting (12–15 January 2023, Las...
Interventions—not neuroimaging—found to be driving increased ischaemic stroke costs
A study by the Neiman Health Policy Institute (Reston, USA) has found that the costs of an ischaemic stroke episode increased by 4.9% from...
Neuralace enrols first patients in AT-PDN study evaluating Axon therapy
Neuralace Medical has announced the commencement of and first patient enrolments in its AT-PDN (Axon therapy and painful diabetic neuropathy) study.
The multicentre AT-PDN study...
Neuroprotection “renaissance” offers hope for improved stroke therapies in future
The “renaissance” of neuro- and cerebroprotective paradigms, coupled with “the advent of new ideas”—such as the concept of ‘transient neuroprotection’ to preserve the penumbra—appears...
First human cases performed with high-frequency imaging offering “unprecedented potential” in...
Gentuity has today announced the first human use of the Vis-M high-frequency optical coherence tomography (HF-OCT) imaging system and probe. As per a company...
Systematic review deems coated stents plus SAPT feasible in ruptured aneurysms
A systematic review and meta-analysis of the “scarce” existing literature has adjudged flow diversion with a coated stent plus single antiplatelet therapy (SAPT) to...
Athersys provides update on ischaemic stroke and haemorrhagic trauma trials of...
Athersys, the company developing MultiStem (invimestrocel)—an off-the-shelf stem cell treatment intended for critical care indications, including acute ischaemic stroke, trauma and other inflammatory conditions—has provided...
Medtronic to highlight sensing-enabled spinal cord stimulation research at NANS 2023
Medtronic has announced that it will highlight clinical and preclinical research relating to sensing-enabled spinal cord stimulation (SCS) therapy at the North American Neuromodulation...
So, you want to be a principal investigator?
A career in clinical research is perhaps a less formulaic and well-trodden path than the one into medicine itself, typically requiring relatively young and...
Synchron announces publication of brain-computer interface clinical trial in JAMA Neurology
Synchron has announced that the medical journal JAMA Neurology has published peer-reviewed, long-term safety results from a clinical study in four patients with severe...
DISTAL trial will elucidate non-dominant M2, M3 and PCA occlusions but...
A recent update on the DISTAL randomised controlled trial (RCT)—which was delivered at the Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference (5–8 December...
SynerFuse announces “milestone” solo spine surgeon procedure in DRG stimulation study
Justin Zenanko, the CEO of SynerFuse, announced today that—in what the company says is a world-first—a solo spine surgeon has performed the “groundbreaking” SynerFuse...
Nalu Medical announces publication of two spinal cord stimulation clinical studies
Nalu Medical—a company working on miniaturised neurostimulation implants for the management of chronic intractable pain via both spinal cord stimulation (SCS) and peripheral nerve...
NeuroNews’ top 10 most popular stories of December 2022
The final weeks of 2022 saw the global burden of stroke gain a great deal of attention from NeuroNews’ online audience, including discussions around...
Mathematical model examines factors influencing risk of cerebral aneurysm rupture
Researchers from India have developed a patient-specific mathematical model to examine and elucidate the parameters—including shape and size—that influence aneurysm rupture risks prior to...
Nevro announces two late-breaking data presentations set for NANS 2023
Nevro Corporation has announced that two abstracts for clinical trials relating to painful diabetic neuropathy (PDN) and non-surgical back pain (NSBP) treatments have been...
Increased annual stroke rate in Canada underscores need for strong treatments...
A new study funded by the Heart and Stroke Foundation has revealed that annual stroke occurrence rates in Canada have increased to 108,707—roughly one every five minutes. This...
Imperative Care announces FDA clearance and initial cases with stroke-specific radial...
Imperative Care announced today that the US Food and Drug Administration (FDA) has finalised 510(k) clearance of its Zoom RDL radial access system—the company’s...
Abbott launches “world’s smallest” implantable, rechargeable SCS system for chronic pain
Abbott has announced the US Food and Drug Administration (FDA) approval of the company's Eterna spinal cord stimulation (SCS) system, which it claims is...
Insightec receives US FDA approval to treat essential tremor patients’ second...
Insightec recently announced it has received an additional US Food and Drug Administration (FDA) approval for treatment of essential tremor using its Exablate Neuro...
Study reveals racial disparity in brain tumour surgeries recommended to US...
A patient’s race may influence the recommendations they receive for the surgical removal of brain tumours, as per a recent, registry-based cohort analysis published...
Deep brain stimulation may fulfil “desperate need” for effective Alzheimer’s therapy
A team including researchers from the USA, Germany and Canada has found that stimulating a specific network in the brain of Alzheimer’s disease patients...
European Stroke Organisation taskforce delivers update on thrombolytic drug shortages
The thrombolysis taskforce of the European Stroke Organisation (ESO) executive committee has provided an update on current shortages of alteplase and tenecteplase, detailing outcomes...
Shelley Renowden
Through her many years as a consultant neuroradiologist at the North Bristol NHS Trust (Bristol, UK), as well as organising the European Course in...
Study indicates safety of novel transmural access to carotid artery perivascular...
A transmural approach for accessing the perivascular tissues of the cervical carotid artery has been deemed safe following initial evaluations in a swine model.
Geoffrey...
Technological advances could render 3D printing a “major manufacturing tool” for...
The utilisation of 3D printing to make drug-eluting stents may currently be in its infancy, but the advantages it carries—such as the ability to...
Proof-of-concept study indicates utility of evoked-interference DBS in Parkinson’s disease
Closed-loop evoked-interference deep brain stimulation (DBS) has been shown to be potentially utilisable in characterising the role of oscillatory dynamics in Parkinson’s disease and...
Sonorous uses new device to treat patients with symptomatic cerebral venous...
Sonorous NV has announced the treatment of the first patients in North America with the BossStent device, which is designed to treat patients with...
Stryker launches “state-of-the-art” neurovascular lab to accelerate stroke care innovation
Stryker recently opened its Neurovascular (NV) lab—a “state-of-the-art” laboratory designed to accelerate stroke-related innovation in the Asia-Pacific region. Located within the Stryker Global Technology...
How do we improve the treatment of stroke patients in the...
This educational supplement has been sponsored by MicroVention.
Since its inception in 1997, MicroVention has gradually expanded its offerings from cerebral aneurysms to include several...
Current literature supports stenting as feasible bailout option after failed thrombectomy
Permanent intracranial stenting offers a feasible, safe ‘bailout’ option following a failed mechanical thrombectomy procedure. This was the concluding message delivered recently by Sarah...
NeuroNews issue 48 – US
Highlights:
With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep...
NeuroNews issue 48 – EU
Highlights:
With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep...
Medtronic Neurovascular partners with Avail to boost real-time connectivity
Medtronic Neurovascular has announced a new partnership with Avail Medsystems, creating the Medtronic Remote Connectivity Program (Medtronic RCP) in the process.
The goal of this...
Spinal cord stimulation and other modalities will benefit from greater understanding...
Despite their clear significance in pain management, gender differences relating to the ways patients respond to neuromodulation therapies are relatively poorly understood and underpinned...
Axonics gains Health Canada approval for fourth-generation rechargeable sacral neuromodulation system
Axonics has announced that Health Canada has approved the company’s fourth-generation rechargeable sacral neuromodulation system as a treatment for bladder and bowel dysfunction.
The newly...
IRRAS receives new US FDA 510(k) clearance for next-generation IRRAflow control...
IRRAS has announced that it recently received regulatory clearance from the US Food and Drug Administration (FDA) to activate all of the functionality on...
Eight winners advance to Phase 2 in Neuromod Prize competition
Eight winners have been exclusively invited to join Phase 2 of the Neuromod Prize, a US$9.8 million competition to accelerate the development of targeted...
NeuroOne successfully completes feasibility study with OneRF ablation system
NeuroOne Medical Technologies has announced that it has successfully completed a feasibility study with its OneRF ablation system—a developing technology that utilises existing implanted...
NeuroNews’ top 10 most popular stories of November 2022
Key announcements from a number of the neurovascular market's leading companies generated interest from NeuroNews' online readers last month, including updates from the recent...
Timothy Deer to receive inaugural NANS Presidential Merit Award
Renowned pain management expert and clinical professor of anaesthesiology Timothy Deer (West Virginia University, Charleston, USA) is set to receive the inaugural Presidential Merit...
Study identifies “urgent need” to reduce burden of ischaemic stroke in...
A study published in Neurology has found that the burden of ischaemic stroke in young adults “continues to increase” across low-socio-demographic index (SDI) regions,...
Intraoperative neuromonitoring may drive a new era in spinal cord stimulation...
“We are entering an era where true scientific evidence from IONM is guiding technology and our clinical practice.” This was one of the...
Clinicians urge Scottish government to reverse £7 million thrombectomy funding cut
Health charities and National Health Service (NHS) clinicians have united in a call for the Scottish government to reverse a cut to the funding...
Stroke community intensifies efforts to tackle “unacceptable” disparities in thrombectomy access
A wealth of new data confirming the beneficial role mechanical thrombectomy can play in the treatment of acute ischaemic stroke came to light through...
AI demonstrates potential to detect carotid artery disease on duplex ultrasound
A prospective study has demonstrated the potential feasibility, applicability and accuracy held by artificial intelligence (AI) in the detection of carotid artery disease on...
Wise receives US FDA clearance for intraoperative monitoring cortical strip
Wise, a company that develops next-generation implantable electrodes for neuromonitoring, neuromodulation and brain-machine interfacing applications, has announced the US Food and Drug Administration (FDA)...
LuSeed Vascular appoints Robert Stern to board of directors
LuSeed Vascular has announced that Robert Stern, an experienced medical device executive and investor, has been nominated as the vice chairman of the company’s...
SNIS: Physicians “should not have to choose” between family life and...
The Society of NeuroInterventional Surgery (SNIS) has released a position statement advocating pregnancy and parental leave policies in neurointerventional surgery, also voicing support for...
NeuroPace initiates feasibility study of responsive neurostimulation for Lennox-Gastaut syndrome
NeuroPace has announced that the first patient with Lennox-Gastaut syndrome (LGS)—a particularly severe form of childhood-onset epilepsy characterised by cognitive dysfunction and frequent seizures—was...
Viz.ai partners with Cercare to support neurovascular clinical decision-making
Viz.ai has announced a partnership with Cercare Medical that will incorporate the latter’s Cercare Perfusion—a fully-automated, simple-to-use, patient-specific perfusion software—into the Viz artificial intelligence...
Neurologica announces US FDA 510(k) clearance of BodyTom 64
Neurologica, a subsidiary of Samsung Electronics, has announced that its head-to-toe trauma imaging solution—the BodyTom 64 point-of-care mobile computed tomography (CT) scanner—has received 510(k) clearance...
Cerevasc co-founders honoured with Innovation Award at SVIN 2022
Two neurosurgeons from Tufts Medical Center in Boston, USA have been honoured with the 2022 Innovation Award at this year’s Society of Vascular and...
Swiss parliament votes to accept US FDA-approved medical devices
The Swiss Federal Assembly has voted in favour of accepting medical devices with US Food and Drug Administration (FDA) marketing authorisation in Switzerland.
A motion...
RSNA 2022: New research improves understanding of ADHD, migraine and post-COVID...
The ongoing annual meeting of the Radiological Society of North America (RSNA; 27 November–1 December 2022, Chicago, USA) has seen a plethora of new...
Vesalio appoints VP of US sales, announces publication of “impressive” first-pass...
Vesalio has today announced the appointment of a new vice president (VP) of US sales, Bob Bushok, who will oversee commercial strategy and execution...
Abbott to receive multiple CES 2023 awards for neurostimulation and pacemaker...
Abbott has been recognised by the Consumer Technology Association (CTA) with three Consumer Electronics Show (CES 2023; 5–8 January, Las Vegas, USA) Innovation Awards...
Aidoc secures new FDA clearances for neurovascular and cardiovascular detection tools
Aidoc has announced it has increased its total number of US Food and Drug Administration (FDA) clearances to 11 with the addition of two...
Viz.ai and Vastrax join forces to accelerate neurovascular clinical trial enrolment
Viz.ai has announced a strategic partnership with full-service, vascular clinical research organisation (CRO) Vastrax. Together, the two companies intend to accelerate clinical trial enrolment for...
Intermittent stimulation of the DRG produces comparable chronic pain results to...
Intermittent dorsal root ganglion stimulation (DRG-S) has been shown to produce comparable results to continuous stimulation across a two-week period, as reported in Neuromodulation:...
Mainstay announces publication of post-market data from ongoing chronic low back...
Mainstay Medical has announced the publication of data from a single-centre, real-world study with one-year clinical follow-up of patients selected from its ReActiv8-C study,...
Avicenna.AI partners with CARPL.ai to provide AI-powered radiology solutions
Avicenna.AI has today announced a distribution agreement with CARPL.ai—a company providing a technology platform that enables service-provider-oriented testing, validation and deployment of artificial intelligence...
NoNO announces first patient dosed with NoNO-42 in Phase 1 study
NoNO Inc has announced the dosing of the first participant in its Phase 1 clinical trial evaluating NoNO-42—a next-generation neuroprotective drug developed in the...
Direct thrombectomy fails to show non-inferiority versus bridging therapy in early...
The international DIRECT-SAFE trial has produced results indicating that intravenous thrombolysis (IVT) plus mechanical thrombectomy—commonly referred to as bridging therapy—should continue to be recommended...
Why responsive neurostimulation is garnering “wide interest” from the epilepsy field
To date, thalamic responsive neurostimulation (RNS) has shown real potential in the treatment of patients with drug-resistant epilepsy. Mark Richardson (Massachusetts General Hospital, Boston,...
Cerenovus reveals positive stent-retriever thrombectomy outcomes within EXCELLENT registry
Cerenovus, part of Johnson & Johnson MedTech, has today announced positive primary outcomes from the real-world EXCELLENT registry, focused on stroke-inducing blood clot removal...
SPR Therapeutics debuts occipital nerve stimulation data at ASRA 2022
At the 21st annual American Society of Regional Anesthesia (ASRA) pain medicine meeting (17–19 November 2022, Orlando, USA), SPR Therapeutics is highlighting five new data sets demonstrating...
Route 92 Medical announces expansion to new manufacturing site in Utah
Route 92 Medical has announced its expansion to a new high-volume manufacturing site in Salt Lake City, USA. This 40,000-square-foot site will allow Route...
IRRAS announces commercial US partnership with Medtronic for IRRAflow system
IRRAS recently announced it has signed a sales agency agreement to promote its IRRAflow system in the USA with Medtronic.
During the initial pilot phase of this...
World Stroke Congress bolsters evidence on optimal thrombectomy and thrombolysis approaches
While much-needed improvements to existing triage and transport protocols for acute stroke patients were a leading topic of focus on World Stroke Day (29...
Collavidence: A global project looking to break down longstanding barriers in...
As per its own mission statement, Collavidence wants to “make medical research collaboration and funding easier, more accessible and more transparent”, paying mind to...
Contego completes enrolment of PERFORMANCE II carotid stent trial
Contego Medical has announced that enrolment of the PERFORMANCE II clinical trial has been completed.
PERFORMANCE II is intended to evaluate the safety and effectiveness...
CVRx launches new version of neuromodulation device intended to treat heart...
CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-approved neuromodulation device to treat the symptoms of heart failure—has launched its new...
Brainomix and Visionable announce partnership to optimise UK stroke care pathway
Brainomix is set to strategically partner with Visionable, a real-time clinical collaboration platform designed to enable virtual healthcare models, in an attempt to transform...
New study finds 85% of aneurysms identified by Viz ANEURYSM had...
Viz.ai has shared highlights from new data set to be presented at next week’s Society of Vascular and Interventional Neuroradiology (SVIN) annual meeting (16–19...
Optically generated focused ultrasound shows promise for non-invasive brain stimulation
In a new paper published in Light: Science and Applications, a team of scientists and engineers led by Ji-Xin Cheng and Chen Yang (Boston...
Rapid ICH receives new US FDA clearance with “highest sensitivity and...
RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...
Positive animal-model results with ABILITY BCI are “important step” towards human...
The Wyss Center for Bio and Neuroengineering in Geneva, Switzerland has today revealed the latest preclinical neural data acquired with its fully implantable ABILITY...
Insightec announces sustained and significant tremor improvement with focused ultrasound thalamotomy
Insightec has announced the publication of what it claims is the largest prospective, long-term follow-up study to date of unilateral magnetic resonance imaging-guided focused...
NeuroNews’ top 10 most popular stories of October 2022
A common theme surrounding last month's World Stroke Day (29 October) was the fact that, while acute ischaemic stroke therapies may have advanced markedly...
New CMS telehealth designation extends coverage of Abbott’s NeuroSphere virtual clinic
As part of its Medicare Telehealth Services List, the US Centers for Medicare and Medicaid Services (CMS) will continue to cover the use of...
iVascular launches new neurovascular portfolio with four CE-marked devices
Vascular device company iVascular has announced the expansion of its therapeutic areas with the launch of a new neurovascular pipeline, having gained CE-mark approval...
BAOCHE trial results supporting thrombectomy for basilar artery stroke published in...
Results from the BAOCHE randomised controlled trial (RCT), which found that the addition of thrombectomy to standard medical care within 6–24 hours in basilar...
Medtronic study finds post-stroke protocols “vary significantly” between community hospitals and...
Medtronic has announced the first results from its DiVERT clinical study, which showed that post-stroke workflow protocols and cardiac monitoring vary significantly across community...
World Stroke Day: WSO to launch new Stroke Certification initiative
On World Stroke Day (29 October 2022), the World Stroke Organization (WSO) has announced the launch of a new programme that aims to drive...
BE FAST: Physicians advocate greater public awareness on World Stroke Day
On World Stroke Day 2022 (29 October), US physicians from the Get Ahead of Stroke campaign are urging the public to embrace the “simple...
Synchron to begin COMMAND trial enrolment at University of Pittsburgh
Synchron has announced that enrolment in the COMMAND trial has commenced at the University of Pittsburgh in Pittsburgh, USA.
The COMMAND trial is an early...
Medtronic announces launch of neurovascular Co-Lab platform
Medtronic has announced the launch of its neurovascular Co-Lab platform, which is designed to accelerate "urgently needed" innovation in stroke care and treatment.
The company...
NICO raises US$12.5 million in oversubscribed investment round
NICO Corporation has completed a US$12.5 million capital raise in an oversubscribed round that will scale the business, and leverage continued progress on the company's recently completed adaptive...
NeuroOne receives US FDA 510(k) clearance to market Evo sEEG system...
NeuroOne Medical Technologies has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its Evo stereoelectroencephalography (sEEG) electrode technology...
Bruce Ovbiagele named editor-in-chief of the Journal of the American Heart...
Bruce Ovbiagele, associate dean and professor of neurology at the University of California San Francisco (UCSF; San Francisco, USA) and chief of staff at...
Philips to highlight latest advances in stroke care at 2022 World...
Royal Philips today announced it will showcase the company’s latest advances to support the treatment of stroke patients at the 14th annual World Stroke...
Vessel-wall imaging could hold the key in “known yet understudied” phenomenon...
Following the publication of a case report in Topics in Magnetic Resonance Imaging, researchers from Malaysia have indicated that the use of vessel-wall imaging...
Axoft launches ‘soft’ brain-implant technology, gains US FDA Breakthrough Device designation
Neurotechnology start-up Axoft has launched and announced US Food and Drug Administration (FDA) Breakthrough Device designation for its brain-machine interface (BMI) technology intended to...
Tenecteplase offers “incredible opportunity” to optimise thrombolytic stroke treatments
Earlier this year, results from the Canadian AcT (Alteplase compared to tenecteplase) randomised controlled trial (RCT) were delivered for the first time at the...
Nerivio neuromodulation device achieves positive results in placebo-controlled migraine trial
Theranica Bio-electronics has announced positive top-line results in its double-blind, randomised, placebo-controlled, multicentre, pivotal clinical trial in the USA. This trial evaluated the efficacy...
RAPID Aneurysm programme shows positive early performance in retrospective study
RAPID Aneurysm, a semi-automated artificial intelligence (AI) software programme (RapidAI), is highly accurate in detecting cerebral aneurysms on computed tomography angiography (CTA) imaging, according...
Vesalio announces EU MDR certification of neurovascular product lines
Vesalio has announced EU Medical Device Regulation (MDR) certification of its product lines—achieving this “significantly ahead” of its May 2023 deadline, according to a...
Systematic review finds “strong evidence base” supporting deep brain stimulation for...
Deep brain stimulation (DBS) can halve the symptoms of severe obsessive-compulsive disorder (OCD), according to the findings of a pooled data analysis of available...
New white paper details early experience with ABILITY brain-computer interface
A new white paper, released by the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), reveals the first neural signals recorded by the ABILITY...
Nevro announces US FDA approval of HFX iQ system to personalise...
Nevro Corporation has announced that it has received approval from the US Food and Drug Administration (FDA) for the Senza HFX iQ spinal cord stimulation (SCS)...
Society of Vascular and Interventional Neurology announces 40-second stroke awareness challenge
The Society of Vascular and Interventional Neurology (SVIN) has said it wants to create awareness around stroke events leading up to World Stroke Day...
NeuroPace announces first patient implant in NAUTILUS pivotal study
NeuroPace has announced the first patient has been implanted in the NAUTILUS clinical trial, a pivotal study that will evaluate the safety and effectiveness...
Neuspera announces first successful Nuvella system implant in second phase of...
Neuspera Medical has announced the first patient has been successfully implanted with the Nuvella system in its pivotal SANS-UUI clinical trial, which will evaluate...
IRRAS announces educational webinar series alongside Jacobs Institute and University of...
IRRAS today announced the launch of a new educational webinar series, entitled “Exploring the Impact of IRRAflow's Active Fluid Exchange: Our Early Experience Utilizing...
Researchers develop injectable biomaterial with potential in endovascular aneurysm treatment
Researchers in the USA have developed an injectable, ‘toothpaste-like’ biomaterial that may offer promise in the treatment of intracranial aneurysms as an alternative to...
Phagenesis announces US launch of neurostimulation system for post-stroke swallowing control
Phagenesis today announced that the US Food and Drug Administration (FDA) has granted a de novo request for the Phagenyx neurostimulation system, which uses...
Process times and regional variation are main areas of concern for...
Technical and clinical outcomes associated with mechanical thrombectomy treatments in England are currently “acceptable”, but ‘drip-and-ship’ patients, process times and variation between units all...
NICO announces completed enrolment in trial evaluating new ICH intervention approach
NICO Corporation has announced that enrolment is now complete for the ENRICH (Early minimally invasive removal of ICH) randomised controlled trial, which is comparing medical and economic outcomes between early...
Physicians should prioritise first-pass optimisation over speed in thrombectomy procedures
Achieving clot retrieval with the fewest possible number of passes is critical in mechanical thrombectomy, and may even hold greater importance than how quickly...
Nevro announces first global manufacturing operation with Costa Rica expansion
Nevro Corporation announced recently that the US Food and Drug Administration (FDA) has approved its manufacturing operations in Costa Rica for the production of its proprietary...
US study bolsters recent evidence supporting tenecteplase in ischaemic stroke care
Tenecteplase, a newer-generation intravenous thrombolysis (IVT) drug, has outperformed the traditional treatment (alteplase) for ischaemic strokes in several key areas, demonstrating better health outcomes...
NeuroNews’ top 10 most popular stories of September 2022
The latest and greatest in neurointerventional clinical research buzzed our readers in September, with new studies on dual antiplatelet therapy (DAPT) duration, radial versus...
Microvention celebrates 25 years in neuroendovascular technologies with ‘Patient’s Day’
Microvention, a wholly owned subsidiary of Terumo Corporation, today celebrated its 25-year anniversary in the neuroendovascular technologies industry.
The capstone of Microvention’s 25th anniversary celebration...
Wallaby/phenox officially announces global launch of Pegasus HPC stent system
Wallaby/phenox has officially announced the successful global launch of its novel Pegasus hydrophilic polymer coating (HPC) stent, having first unveiled the device at the 2022...
HD-RECOVERY: Brain stimulation improves COVID-19 outcomes in randomised trial
In the randomised HD-RECOVERY clinical trial, the use of high-definition transcranial direct current stimulation (HD-tDCS) has been found to be associated with a statistically...
Magnus receives US FDA clearance for SAINT neuromodulation system in severe...
Magnus Medical has announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its SAINT neuromodulation system for the treatment of...
Flow diverting, stenting and beyond—HPC technology offers “limitless” potential in neurointervention
This advertorial is sponsored by phenox.
Following the publication of a study assessing the use of Hydrophilic Polymer Coating (HPC) technology with the p64 MW...
UK NICE publishes interventional procedure guidance for ReActiv8 restorative neurostimulation
Mainstay Medical has announced that the National Institute for Health and Care Excellence (NICE), a public body of the UK Department of Health, has...
SWIFT-DIRECT sub-analysis finds effect of bridging thrombolysis is preserved over time
A recent sub-analysis of the SWIFT-DIRECT trial, which is published in the Journal of NeuroInterventional Surgery (JNIS), has found “no evidence” that the effect...
Nerivio demonstrates comparable effectiveness to standard-care medications in chronic migraine
Theranica has announced the publication of a new study comparing the effectiveness of Remote electrical neuromodulation (REN) to that of standard-care medications for the acute treatment...
Vesalio announces US FDA approval of NeVa VS to treat cerebral...
Vesalio has announced US Food and Drug Administration (FDA) humanitarian device exemption (HDE) approval for commercialisation of its NeVa VS device, which is indicated...
Similar complication rates observed following DAPT discontinuation within and past 90...
The duration of dual antiplatelet therapy (DAPT), either 30–90 days or more than 90 days, following implantation of a flow diverter in cerebral aneurysm...
Aleva Neurotherapeutics gains European MRI approval for deep brain stimulation system
Aleva Neurotherapeutics has announced CE-mark approval of its magnetic resonance imaging (MRI) labelling for the directSTIM deep brain stimulation (DBS) system, allowing the technology...
Sheba and Thomas Jefferson to build “state-of-the-art” neuroscience centre in Israel
Sheba Medical Center, which is located in Ramat Gan, Israel and claims to be the country’s largest medical centre, has announced a major collaboration...
The inevitable growth of neurovascular robotics: Improved precision today, potential remote...
This advertorial, sponsored by Siemens Healthineers, is intended for readers outside of the USA.
The majority of cases the CorPath GRX Neurovascular Robotic System (Siemens...
Adjunctive therapy demonstrates comparable aneurysm occlusion rates to established flow diverters
The Neqstent coil-assisted flow diverter (Cerus Endovascular) has demonstrated comparable occlusion rates to those seen with other, similar flow diversion technologies, as well as...
Onward reports positive study results in restoring arm and hand function...
Onward Medical recently announced that the Up-LIFT pivotal study evaluating its non-invasive spinal cord stimulation (SCS) ARC-EX therapy achieved its primary effectiveness endpoint of...
CorPath GRX robot demonstrates safety and effectiveness in neurovascular aneurysm treatment
Corindus, a Siemens Healthineers company, announced today the recent presentation of results from a “first-of-its-kind” study demonstrating the safety and effectiveness of robotic-assisted neurovascular...
Increased coiling rate suggests shift towards endovascular techniques during COVID-19 pandemic
A global study published in the Journal of Neurology, Neurosurgery and Psychiatry (JNNP) has revealed that, while ruptured aneurysm clipping rates remained largely unchanged,...
How AI, automation, robotics and other innovations in ultrasound are improving...
Robert Hamilton (Los Angeles, USA) outlines several key milestones in the history of stroke care, and discusses how recent technological advances in this space...
Axonics announces first patient implants in Canada with recharge-free sacral neuromodulation...
Axonics has announced the first patient implants in Canada with Axonics F15, the company’s newly developed, long-lived, fully recharge-free sacral neuromodulation (SNM) system.
The University...
Basecamp Vascular announces first-in-human cases with steerable mechatronic guidewire
Basecamp Vascular (BCV) has announced a “major step” in the development and evaluation of steerable mechatronic guidewires for stroke treatment via its GECKO system....
Self-administered tDCS reduces knee osteoarthritis pain in older adult patients
Home-based, self-administered transcranial direct current stimulation (tDCS) has demonstrated feasibility, acceptability and significant reductions in clinical pain intensity in older adults with knee osteoarthritis,...
Penumbra announces European launch of RED reperfusion catheters for stroke care
Penumbra announced today that its RED reperfusion catheters have secured a CE mark and are now commercially available in Europe. The catheters are part of...
Isil Saatci
Isil Saatci has been practising interventional neuroradiology (INR) in Ankara, Turkey for almost the entirety of her career—initially at Hacettepe University, where she also...
Nevro announces positive coverage updates for treatment of painful diabetic neuropathy...
Nevro Corporation has announced that US health plan Aetna has updated its spinal cord stimulation (SCS) coverage policy to explicitly cover painful diabetic neuropathy...
Insightec announces financing up to US$200 million to support continued growth
Insightec has announced that it has signed a credit facility for up to US$200 million with affiliates of existing shareholders, Perceptive Advisors and Community Fund....
NeuroNews’ top 10 most popular stories of August 2022
In August, NeuroNews’ most read stories included new clinical data on a number of neurovascular technologies, physician viewpoints on a “historic” neurointerventional procedure in...
Neurofenix completes US$7 million Series A funding for digital stroke and...
Neurofenix has raised US$7 million in Series A funding via a round led by AlbionVC, with additional participation from HTH, InHealth Ventures, and existing...
Brainomix awarded tender to roll out AI imaging software across all...
Brainomix has announced that it has been awarded the national tender in Hungary to deploy its artificial intelligence (AI) stroke imaging software across all stroke centres...
Vesalio gains CE-mark approval for new “one-of-a-kind” NeVa NET thrombectomy device
Vesalio has today announced receipt of CE-mark approval for commercialisation of its new NeVa NET, which the company claims is the “first and only”...
Gimer Medical granted IDE approval for spinal cord stimulation system
Gimer Medical today announced that the company’s spinal cord stimulation (SCS) system was granted conditional investigational device exemption (IDE) approval by US Food and...
NeuroNews issue 47 – US
Highlights:
Details and comment on the first US implantation of the Stentrode brain-computer interface device (Synchron) lead a number of late-breaking presentations from this...
NeuroNews issue 47 – EU
Highlights:
Details and comment on the first US implantation of the Stentrode brain-computer interface device (Synchron) lead a number of late-breaking presentations from this...
New-look ESMINT congress to reflect on ISAT study and prioritise international...
After a long period of uncertainty triggered by a worldwide pandemic, the 2022 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (7–9 September,...
Abnormal DW-MRI foci “significantly more frequent” with radial versus femoral access
A prospective analysis of 200 consecutive diagnostic cerebral angiograms has indicated that the number of diffusion-weighted magnetic resonance imaging (DW-MRI) restriction foci was “significantly...
Theranica secures US$45 million through Series C funding round
Theranica has announced the closing of its Series C funding round, with a first closing of US$45 million. New Rhein Healthcare Investors led the...
CereVasc announces first treatment in US trial evaluating eShunt for normal-pressure...
CereVasc today announced completion of the first eShunt procedure in the USA as part of a pilot study involving normal-pressure hydrocephalus (NPH) patients.
The study is being conducted...
MicroPort Neurotech receives Japanese marketing approval for Numen coil embolisation system
MicroPort Neurotech today announced that it has received marketing approval issued by the Ministry of Health, Labour and Welfare of Japan for its independently...